ATE281836T1 - Stabilisierte tibolone zubereitungen - Google Patents

Stabilisierte tibolone zubereitungen

Info

Publication number
ATE281836T1
ATE281836T1 AT98928214T AT98928214T ATE281836T1 AT E281836 T1 ATE281836 T1 AT E281836T1 AT 98928214 T AT98928214 T AT 98928214T AT 98928214 T AT98928214 T AT 98928214T AT E281836 T1 ATE281836 T1 AT E281836T1
Authority
AT
Austria
Prior art keywords
preparations
tibolone
stabilized
stabilized tibolone
tibolone preparations
Prior art date
Application number
AT98928214T
Other languages
German (de)
English (en)
Inventor
De Pieter Haan
Adrianus Cornelis Petru Rovers
Hurk Theodora Ant Lambregts-De
Jocominus Antonius Ma Zwinkels
Ryoichi Morita
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE281836T1 publication Critical patent/ATE281836T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98928214T 1997-04-22 1998-04-20 Stabilisierte tibolone zubereitungen ATE281836T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97201180 1997-04-22
PCT/EP1998/002361 WO1998047517A1 (en) 1997-04-22 1998-04-20 Stabilized tibolone compositions

Publications (1)

Publication Number Publication Date
ATE281836T1 true ATE281836T1 (de) 2004-11-15

Family

ID=8228228

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98928214T ATE281836T1 (de) 1997-04-22 1998-04-20 Stabilisierte tibolone zubereitungen

Country Status (25)

Country Link
US (6) US6399594B2 (enExample)
EP (1) EP0975348B1 (enExample)
JP (1) JPH10316573A (enExample)
KR (1) KR100580855B1 (enExample)
CN (2) CN1146424C (enExample)
AR (1) AR012480A1 (enExample)
AT (1) ATE281836T1 (enExample)
AU (1) AU742037B2 (enExample)
BR (1) BR9809268A (enExample)
CA (1) CA2288070A1 (enExample)
DE (1) DE69827484T2 (enExample)
DK (1) DK0975348T3 (enExample)
ES (1) ES2232949T3 (enExample)
HU (1) HUP0001780A3 (enExample)
ID (1) ID22763A (enExample)
IL (1) IL123984A (enExample)
NO (1) NO995127L (enExample)
NZ (1) NZ338028A (enExample)
PL (1) PL190227B1 (enExample)
PT (1) PT975348E (enExample)
RU (1) RU2207133C2 (enExample)
TR (1) TR199902530T2 (enExample)
TW (1) TW570798B (enExample)
WO (1) WO1998047517A1 (enExample)
ZA (1) ZA983169B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW577893B (en) 1998-10-16 2004-03-01 Akzo Nobel Nv High purity composition comprising (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
DE60040214D1 (de) * 1999-02-26 2008-10-23 Shionogi & Co Kaubare weichkapseln mit verbesserten verabreichungseigenschaften sowie verfahren zu deren herstellung
US20040229854A1 (en) * 2000-11-28 2004-11-18 Pieter Haan De Immediate release dosage form for HRT
ES2398910T3 (es) * 2001-09-28 2013-03-22 Tntgamble, Inc. Sistema de aporte para componentes biológicos
US20070098784A1 (en) 2001-09-28 2007-05-03 Nutraceutix, Inc. Delivery system for biological component
GB0125061D0 (en) * 2001-10-18 2001-12-12 Norton Healthcare Ltd Pharmaceutical composition
TW200418525A (en) * 2002-11-20 2004-10-01 Akzo Nobel Nv Coated pharmaceutical tablets containing Tibolone
CN1324041C (zh) * 2003-04-01 2007-07-04 上海迪赛诺医药科技开发有限公司 替勃龙晶型i的制备方法
JP5207432B2 (ja) * 2003-04-29 2013-06-12 エム・エス・ディー・オス・ベー・フェー アンチ溶媒凝固プロセス
KR20050038590A (ko) * 2003-05-23 2005-04-27 엔.브이. 오가논 다형성 티볼론을 포함하는 즉시-방출형 약학 제형
US20070231398A1 (en) * 2004-05-05 2007-10-04 Van Lare Cornelis E J Antisolvent Emulsion Solidification Process
WO2005117899A1 (en) * 2004-06-02 2005-12-15 Cipla Limited Pharmaceutical composition comprising tibolone and process for procuding the same
WO2005120517A1 (en) * 2004-06-07 2005-12-22 Strides Arcolab Limited Stable liquid suspension formulation comprising synthetic steroids and process for producing the same
CZ300465B6 (cs) * 2007-07-25 2009-05-27 Zentiva, A. S. Zpusob výroby komprimované farmaceutické formulace s obsahem tibolonu
CN102085193B (zh) * 2009-12-08 2013-11-06 北京以岭生物工程技术有限公司 一种替勃龙口腔崩解片及其制备方法
CN104345098B (zh) * 2013-08-05 2016-04-13 华润紫竹药业有限公司 一种测定替勃龙片剂中抗氧剂含量的方法
US10736907B2 (en) 2016-05-04 2020-08-11 Novalon S.A. Use of sugar-alcohols in tibolone compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4701450A (en) 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
CH676470A5 (enExample) * 1988-02-03 1991-01-31 Nestle Sa
IE63051B1 (en) * 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
DE69418744T2 (de) * 1993-03-05 1999-11-11 Akzo Nobel N.V., Arnheim/Arnhem Verwendung von Pregnanderivaten zur Behandlung von Tumoren
JPH09504271A (ja) 1993-09-03 1997-04-28 スミスクライン・ビーチャム・コーポレイション 安定した錠剤処方
IL115445A (en) 1994-10-17 1999-08-17 Akzo Nobel Nv Solid pharmaceutical compositions comprising low dosage active ingredient oil and excipient capable of binding water and their preparation

Also Published As

Publication number Publication date
NO995127D0 (no) 1999-10-21
NZ338028A (en) 2001-10-26
US20040142031A1 (en) 2004-07-22
IL123984A (en) 2004-09-27
PL336658A1 (en) 2000-07-03
ES2232949T3 (es) 2005-06-01
US6399594B2 (en) 2002-06-04
TW570798B (en) 2004-01-11
CA2288070A1 (en) 1998-10-29
CN1146424C (zh) 2004-04-21
CN1253503A (zh) 2000-05-17
TR199902530T2 (xx) 2000-05-22
US20030119801A1 (en) 2003-06-26
PL190227B1 (pl) 2005-11-30
NO995127L (no) 1999-10-21
AU8014698A (en) 1998-11-13
US20010005513A1 (en) 2001-06-28
BR9809268A (pt) 2000-06-27
HUP0001780A2 (hu) 2000-12-28
JPH10316573A (ja) 1998-12-02
US20040142030A1 (en) 2004-07-22
DK0975348T3 (da) 2005-03-07
AU742037B2 (en) 2001-12-13
EP0975348B1 (en) 2004-11-10
US6514958B1 (en) 2003-02-04
HUP0001780A3 (en) 2001-02-28
WO1998047517A1 (en) 1998-10-29
ZA983169B (en) 1998-10-20
KR100580855B1 (ko) 2006-05-17
DE69827484T2 (de) 2005-03-17
ID22763A (id) 1999-12-09
US20040142028A1 (en) 2004-07-22
PT975348E (pt) 2005-01-31
DE69827484D1 (de) 2004-12-16
AR012480A1 (es) 2000-10-18
KR20010020163A (ko) 2001-03-15
EP0975348A1 (en) 2000-02-02
HK1023508A1 (en) 2000-09-15
RU2207133C2 (ru) 2003-06-27
CN1494908A (zh) 2004-05-12

Similar Documents

Publication Publication Date Title
DK0921796T3 (da) Tetrahydrolipstatinholdige præparater
DE69821872D1 (de) Teriparatidhaltige stabilisierte Lösungen
ATA93198A (de) Fluoxetinpellets
ID24529A (id) Turunan-turunan 9-oksima eritromisin
NO20001494L (no) Overligger
DE69827484D1 (de) Stabilisierte tibolone zubereitungen
DK1109450T3 (da) Mikrokapselpræparater
DE59707298D1 (de) Desodorierende zubereitungen
ATA111897A (de) Kimme
FI973171A0 (fi) Foerfarande foer drift av arbetsfartyg
NO20002555L (no) Skjøt
ATE246494T1 (de) Brausezubereitungen
DK0862850T3 (da) Mejetærsker
PT1015447E (pt) Derivado piperidinilmetiloxazolidinona
ID23663A (id) Persiapan kaprolaktam
FR2770103B1 (fr) Bigoudi perfectionne
ATA86797A (de) Verschleissschuh
KR980001295U (ko) 개량 도장
ATA46498A (de) Kunststoffgleitbahn
ITDP970013A1 (it) Ruota singola - attrezzo sportivo - cicloidi
KR970053403U (ko) 개량 제기
ATA159297A (de) Immuntolerante prothrombinkomplex-präparation
FIU970474U0 (fi) Suojakatos
SE9704532D0 (sv) Kortställ
BR7702215U (pt) Conjunto pia-fogão

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0975348

Country of ref document: EP

REN Ceased due to non-payment of the annual fee